author-photo

F. Zanelli

Academy for Urban School Leadership

4

Papers

24

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced malignant pleural mesothelioma (MPM): Results of Italian Rames Study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
1842OMutational profile of malignant pleural mesothelioma (MPM) in the phase II RAMES study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)